Home / Amgen Inc. (AMGN)

Amgen Inc. (AMGN) Technical Analysis

Updated: 2026-06-16 09:31 UTC · Last close: 350.53 (-1.31%) · Support: 342.33 · Resistance: 388.16
Amgen Inc. (AMGN) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
342.33
⬆️ Resistance
388.16
🚀 Bullish Trigger
a clean close above 363.84 would strengthen the upside continuation case.
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
57.5
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 342.33 and resistance around 363.84. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 310.90, so a violation there would materially change the current setup narrative.
📊 Technical Summary
At a glance
Trend
Constructive
Momentum
Neutral
Range
68% of 52W range
Key Zone
342.33 / 388.16
Amgen Inc. (AMGN) closed at 350.53 (-1.31%). Trend remains constructive above MA50 and MA200. Momentum stays positive (+7.42%); 52W position: 67% of range; and Volatility: ATR14 2.60%. RSI(14) stands around 57.5, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further.
🎯
Pattern: The chart is currently flagging Double bottom.
🎯
Key levels: Key levels The nearest decision zone is framed by support at 342.33 and resistance at 388.16.
⚠️
Risk: A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Moderate 💰 Profit: Strong 💵 Cash: Pressured 🛡 Balance: Stretched
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is strong and still improving from an earlier dip.
💵 Revenue
8.62B
📈 Net Income
1.82B
🧮 EPS (Basic)
3.37
🏢 Company
Amgen Inc.
🏷 Sector
Healthcare
🧩 Industry
Biotech
Compare with related stocks
Same sector and industry ideas for deeper research
Axsome Therapeutics (AXSM) technical analysisBeam Therapeutics (BEAM) technical analysisCRISPR Therapeutics AG (CRSP) technical analysisAmicus Therapeutics (FOLD) technical analysisImmunitybio (IBRX) technical analysisImmunome (IMNM) technical analysisAbbVie (ABBV) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
AMGN Chart